1. Home
  2. WVE vs FWRD Comparison

WVE vs FWRD Comparison

Compare WVE & FWRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • FWRD
  • Stock Information
  • Founded
  • WVE 2012
  • FWRD 1981
  • Country
  • WVE Singapore
  • FWRD United States
  • Employees
  • WVE N/A
  • FWRD N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • FWRD Oil Refining/Marketing
  • Sector
  • WVE Health Care
  • FWRD Consumer Discretionary
  • Exchange
  • WVE Nasdaq
  • FWRD Nasdaq
  • Market Cap
  • WVE 915.6M
  • FWRD 909.4M
  • IPO Year
  • WVE 2015
  • FWRD 1993
  • Fundamental
  • Price
  • WVE $8.31
  • FWRD $18.01
  • Analyst Decision
  • WVE Strong Buy
  • FWRD Buy
  • Analyst Count
  • WVE 14
  • FWRD 4
  • Target Price
  • WVE $20.79
  • FWRD $33.67
  • AVG Volume (30 Days)
  • WVE 3.6M
  • FWRD 946.1K
  • Earning Date
  • WVE 11-07-2025
  • FWRD 11-05-2025
  • Dividend Yield
  • WVE N/A
  • FWRD N/A
  • EPS Growth
  • WVE N/A
  • FWRD N/A
  • EPS
  • WVE N/A
  • FWRD N/A
  • Revenue
  • WVE $93,946,000.00
  • FWRD $2,520,908,000.00
  • Revenue This Year
  • WVE N/A
  • FWRD $3.91
  • Revenue Next Year
  • WVE $6.26
  • FWRD $6.53
  • P/E Ratio
  • WVE N/A
  • FWRD N/A
  • Revenue Growth
  • WVE N/A
  • FWRD 35.18
  • 52 Week Low
  • WVE $5.28
  • FWRD $9.79
  • 52 Week High
  • WVE $16.74
  • FWRD $39.89
  • Technical
  • Relative Strength Index (RSI)
  • WVE 56.37
  • FWRD 30.01
  • Support Level
  • WVE $8.18
  • FWRD $18.63
  • Resistance Level
  • WVE $9.75
  • FWRD $20.52
  • Average True Range (ATR)
  • WVE 0.64
  • FWRD 1.42
  • MACD
  • WVE 0.14
  • FWRD 0.05
  • Stochastic Oscillator
  • WVE 48.94
  • FWRD 38.37

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About FWRD Forward Air Corporation

Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight, Omni Logistics, and Intermodal and Corporate. The company generates maximum revenue from the Omni Logistics segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in the United States, Canada, and Mexico.

Share on Social Networks: